NEW YORK, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in The Chemours Company (NYSE: CC) that a securities fraud class action has been filed on behalf of shareholders who purchased securities between February 20, 2026 and August 4, 2026. Find out if you could qualify to recover your losses. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.
Opteon refrigerant sales rose a record 37% in the fourth quarter of 2025. Two quarters later, company-wide volumes fell 4%, primarily on weaker Opteon aftermarket sales, and Chemours shares dropped 18.63% in a single session. Applications to serve as lead plaintiff must be filed by December 7, 2026.
At its core, this is a specialty chemical securities fraud case built on allegedly overstated Opteon aftermarket demand. The complaint alleges that the Company failed to disclose that aftermarket demand for its Opteon products was decreasing because those products had been oversold during the preceding fiscal year.
The U.S. AIM Act Factor
Congress enacted the American Innovation and Manufacturing Act in December 2020, and federal regulation has reshaped refrigerant demand since then. The law directed the U.S. Environmental Protection Agency to oversee a shift toward alternative refrigerants with a lesser ozone impact. According to the lawsuit, the stationary air conditioning transition under that law triggered an initial aftermarket channel fill in 2025 as distributors and technicians stocked up for new equipment installations.
The lawsuit contends that this surge left 2026 aftermarket sales lapping an unusually strong prior-year base. That base was allegedly inflated by customer stockpiling rather than lasting end-user demand.
Key Opteon Demand Securities Fraud Allegations for Shareholders
- Record Opteon growth in late 2025 allegedly reflected aftermarket customers building extra inventory, not sustainable end-market consumption.
- Customers allegedly entered 2026 holding excess product, which left the aftermarket channel oversupplied as the new year began.
- Purchasing during 2025 supply constraints allegedly pulled aftermarket sales forward from 2026, leaving less demand for the year ahead.
- The Company cited reduced Opteon blend aftermarket sales in North America as the main driver of its 2026 volume decline.
- The alleged overselling centers on the Thermal & Specialized Solutions segment, which reports Opteon results and anchored the Company's growth story.
"This case presents important questions about demand disclosure obligations in the specialty chemical sector, particularly when a regulatory transition sparks a one-time buying wave. The lawsuit claims that record Opteon sales in 2025 masked an oversupplied aftermarket channel that would weigh on the following year. Shareholders are entitled to understand whether reported growth reflects durable demand." -- Joseph E. Levi, Esq.
Submit your information here or call (212) 363-7500.
WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.
Frequently Asked Questions About the CC Lawsuit
Q: Who is eligible to join the CC investor lawsuit? A: Investors who purchased CC stock or securities between February 20, 2026 and August 4, 2026 and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses -- not on whether you still hold the shares.
Q: What specific misstatements does the CC lawsuit allege? A: The complaint alleges The Chemours Company made materially false or misleading statements during the Class Period regarding aftermarket demand for its Opteon refrigerant products. It also alleges the Company failed to disclose that 2025 sales had oversupplied the distribution channel heading into 2026. When second quarter 2026 results reporting lower Opteon aftermarket sales were disclosed, the stock price declined sharply.
Q: What court was the CC class action filed in? A: The case was filed in the United States District Court for the District of Delaware, governed by the Private Securities Litigation Reform Act of 1995.
Q: What is a lead plaintiff and why does it matter? A: A lead plaintiff is the investor appointed by the court to represent the entire class. Lead plaintiffs are typically investors with the largest documented losses. Being appointed does not increase individual recovery but gives direct oversight of how the case is run.
Q: What if I already sold my CC shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought during the Class Period and sold at a loss may still be eligible to participate.
Q: What does it cost me to participate? A: There is no upfront cost to submit your information and review whether you may be eligible to recover. Should you choose to participate in the securities class action, they are generally handled on a contingency basis, with any attorneys' fees and expenses subject to court approval.
Q: How long will the lawsuit take to resolve? A: Securities class actions typically take two to four years from initial filing to resolution. Timing depends on the court schedule, case developments, and whether the matter is dismissed, settled, or litigated further.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
Tel: (212) 363-7500
Fax: (212) 363-7171
Attorney Advertising. Prior results do not guarantee similar outcomes.
